Income Statement Noevir Holdings Co., Ltd.

Equities

4928

JP3760450001

Personal Products

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-01-15 am EST			5-day change	1st Jan Change
4,660.00 ^JPY	-0.43%		-2.41%	-4.80%

Nov. 08	Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2025	CI
Nov. 07	Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	CI

8e0bb6c28b3fbd0d5cc3cb368f84f29.XvxHxXVHQHBQsowkcrYk69XAJTDVnYjOIbkwePsT_GY.OYkrrUwYEwgS4-tGJcBwxoatSwGipey7ZNxyNYtnjD4rnQSHFhMhQDbzuA

Published financial data: NOEVIR HOLDINGS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2020	2021	2022	2023	2024
Revenues	51.84B	51.27B	61.14B	62.55B	63.82B
Total Revenues	51.84B	51.27B	61.14B	62.55B	63.82B
Cost of Goods Sold, Total	18.76B	18.24B	19.05B	19.99B	20.67B
Gross Profit	33.08B	33.03B	42.09B	42.56B	43.16B
Selling General & Admin Expenses, Total	22.83B	22.44B	31.98B	31.54B	31.73B
R&D Expenses	1.06B	1.04B	-	-	-
Depreciation & Amortization - (IS)	1.13B	989M	-	-	-
Other Operating Expenses, Total	25.02B	24.47B	31.98B	31.54B	31.73B
Operating Income	8.06B	8.56B	10.12B	11.02B	11.42B
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	22M	25M	28M	54M	76M
Net Interest Expenses	22M	25M	28M	54M	76M
Currency Exchange Gains (Loss)	2M	39M	103M	1M	-24M
Other Non Operating Income (Expenses)	156M	349M	158M	215M	117M
EBT, Excl. Unusual Items	8.24B	8.97B	10.4B	11.29B	11.59B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-5M	-6M	103M	3M	25M
Asset Writedown	-3M	-	-310M	-	-
Other Unusual Items	-1M	-	961M	-	-
EBT, Incl. Unusual Items	8.23B	8.96B	11.16B	11.3B	11.62B
Income Tax Expense	2.55B	2.51B	3.51B	3.48B	3.53B
Earnings From Continuing Operations	5.68B	6.46B	7.65B	7.81B	8.09B
Net Income to Company	5.68B	6.46B	7.65B	7.81B	8.09B
Minority Interest	-63M	-76M	-64M	-140M	-118M
Net Income - (IS)	5.62B	6.38B	7.59B	7.67B	7.97B
Net Income to Common Incl Extra Items	5.62B	6.38B	7.59B	7.67B	7.97B
Net Income to Common Excl. Extra Items	5.62B	6.38B	7.59B	7.67B	7.97B
Per Share Items
Net EPS - Basic	164.48	186.88	222.18	224.64	233.34
Basic EPS - Continuing Operations	164.48	186.88	222.18	224.64	233.34
Basic Weighted Average Shares Outstanding	34.16M	34.16M	34.16M	34.16M	34.16M
Net EPS - Diluted	164.48	186.88	222.18	224.64	233.34
Diluted EPS - Continuing Operations	164.48	186.88	222.18	224.64	233.34
Diluted Weighted Average Shares Outstanding	34.16M	34.16M	34.16M	34.16M	34.16M
Normalized Basic EPS	148.95	161.93	188.52	202.56	208.68
Normalized Diluted EPS	148.95	161.93	188.52	202.56	208.68
Dividend Per Share	205	210	215	220	225
Payout Ratio	121.52	109.7	94.43	95.67	94.38
Supplemental Items
EBITDA	9.76B	10.05B	11.57B	12.24B	12.43B
EBITA	8.09B	8.59B	10.15B	11.06B	11.46B
EBIT	8.06B	8.56B	10.12B	11.02B	11.42B
Effective Tax Rate - (Ratio)	30.99	27.95	31.42	30.84	30.38
Normalized Net Income	5.09B	5.53B	6.44B	6.92B	7.13B
Non-Cash Pension Expense	57M	12M	25M	9M	10M
Supplemental Operating Expense Items
Advertising Expense	5.2B	4.88B	2.88B	2.72B	2.82B
Selling and Marketing Expenses	5.2B	4.88B	11.06B	10.69B	10.92B
Research And Development Expense From Footnotes	1.06B	1.04B	1.06B	1.03B	1.07B

Fiscal Period: September	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	29.46B	31.1B	29.75B	28.88B	29.22B
Total Cash And Short Term Investments	29.46B	31.1B	29.75B	28.88B	29.22B
Accounts Receivable, Total	9.21B	9.29B	8.96B	10.49B	10.78B
Other Receivables	3.03B	2.84B	3.39B	3.06B	-
Total Receivables	12.24B	12.12B	12.35B	13.55B	10.78B
Inventory	8.08B	7.33B	7.85B	8.15B	8.09B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	641M	574M	619M	600M	2.05B
Total Current Assets	50.42B	51.13B	50.57B	51.18B	50.15B
Net Property Plant And Equipment	23.02B	22.04B	20.69B	20.19B	19.91B
Long-term Investments	3.61B	4.14B	3.37B	3.72B	4.24B
Goodwill	271M	240M	209M	178M	158M
Other Intangibles, Total	159M	191M	209M	521M	836M
Deferred Tax Assets Long-Term	2.57B	2.7B	1.73B	1.46B	1.19B
Other Long-Term Assets, Total	2M	1M	2M	1M	1M
Total Assets	80.05B	80.45B	76.78B	77.25B	76.47B
Liabilities
Accounts Payable, Total	2.15B	2.59B	2.94B	2.9B	2.95B
Accrued Expenses, Total	101M	102M	101M	97M	97M
Current Portion of Leases	112M	112M	93M	87M	86M
Current Income Taxes Payable	3.51B	4.05B	4.28B	5.16B	3.66B
Other Current Liabilities	1.71B	1.78B	2.24B	2.26B	2.53B
Total Current Liabilities	7.58B	8.64B	9.65B	10.51B	9.32B
Long-Term Leases	1.11B	1B	912M	827M	742M
Pension & Other Post Retirement Benefits	5.25B	5.53B	514M	534M	557M
Deferred Tax Liability Non Current	596M	492M	311M	461M	658M
Other Non Current Liabilities	13.27B	12.56B	13.01B	11.71B	11.29B
Total Liabilities	27.81B	28.22B	24.4B	24.04B	22.57B
Common Stock, Total	7.32B	7.32B	7.32B	7.32B	7.32B
Retained Earnings	43.66B	43.04B	42.98B	43.31B	43.77B
Treasury Stock	-	-1M	-1M	-1M	-2M
Comprehensive Income and Other	996M	1.57B	1.76B	2.16B	2.39B
Total Common Equity	51.98B	51.92B	52.06B	52.79B	53.48B
Minority Interest	265M	306M	328M	415M	428M
Total Equity	52.24B	52.23B	52.38B	53.2B	53.9B
Total Liabilities And Equity	80.05B	80.45B	76.78B	77.25B	76.47B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34.16M	34.16M	34.16M	34.16M	34.16M
ECS Total Common Shares Outstanding	34.16M	34.16M	34.16M	34.16M	34.16M
Book Value / Share	1.52K	1.52K	1.52K	1.55K	1.57K
Tangible Book Value	51.55B	51.49B	51.64B	52.09B	52.48B
Tangible Book Value Per Share	1.51K	1.51K	1.51K	1.53K	1.54K
Total Debt	1.22B	1.11B	1B	914M	828M
Net Debt	-28.23B	-29.99B	-28.74B	-27.97B	-28.4B
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.25B	5.53B	514M	534M	557M
Minority Interest, Total (Incl. Fin. Div)	265M	306M	328M	415M	428M
Inventories - Raw Materials, Total	1.38B	1.26B	1.47B	1.65B	1.67B
Inventories - Work In Process, Total	90M	116M	140M	141M	112M
Inventories - Finished Goods, Total	6.6B	5.95B	6.24B	6.35B	6.31B
Full Time Employees	1.51K	1.45K	1.4K	1.37K	1.37K
Accumulated Allowance for Doubtful Accounts (Supple)	19M	20M	7M	6M	5M

Fiscal Period: September	2020	2021	2022	2023	2024
Net Income	8.23B	8.97B	11.16B	11.3B	11.62B
Depreciation & Amortization - CF	1.67B	1.46B	1.42B	1.19B	977M
Amortization of Goodwill and Intangible Assets - (CF)	31M	31M	31M	31M	32M
Depreciation & Amortization, Total	1.7B	1.49B	1.45B	1.22B	1.01B
(Gain) Loss From Sale Of Asset	5M	6M	207M	-2M	-24M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-3.51B	-1.91B	-3.38B	-1.92B	-2.16B
Change In Accounts Receivable	1.62B	-47M	-343M	-1.52B	-298M
Change In Inventories	569M	801M	-284M	-261M	46M
Change In Accounts Payable	-562M	413M	282M	-39M	50M
Change in Other Net Operating Assets	-743M	-656M	-3.25B	-1.15B	-1.11B
Cash from Operations	7.31B	9.06B	5.84B	7.62B	9.12B
Capital Expenditure	-1.64B	-376M	-546M	-736M	-626M
Sale of Property, Plant, and Equipment	-	20M	312M	10M	37M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-12M	-57M	-67M	-316M	-384M
Investment in Marketable and Equity Securities, Total	34M	-1M	46M	-2.5B	2.5B
Other Investing Activities, Total	-2M	-2M	-	-1M	-1M
Cash from Investing	-1.62B	-416M	-255M	-3.54B	1.52B
Repurchase of Common Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-6.83B	-7B	-7.17B	-7.34B	-7.52B
Common & Preferred Stock Dividends Paid	-6.83B	-7B	-7.17B	-7.34B	-7.52B
Other Financing Activities, Total	-135M	-179M	-214M	-152M	-190M
Cash from Financing	-6.96B	-7.18B	-7.38B	-7.49B	-7.71B
Foreign Exchange Rate Adjustments	16M	159M	479M	49M	-96M
Miscellaneous Cash Flow Adjustments	-	16M	1M	-	-
Net Change in Cash	-1.25B	1.64B	-1.31B	-3.36B	2.84B
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	3.51B	2.3B	3.37B	1.98B	2.16B
Levered Free Cash Flow	5.36B	8.4B	7.4B	6.45B	7.32B
Unlevered Free Cash Flow	5.36B	8.4B	7.4B	6.45B	7.32B
Change In Net Working Capital	-268M	-1.99B	-238M	611M	-185M

Fiscal Period: September	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.17	6.67	8.04	8.95	9.29
Return on Total Capital	9.35	10.02	11.85	12.82	13.12
Return On Equity %	10.8	12.36	14.63	14.8	15.1
Return on Common Equity	10.73	12.29	14.6	14.64	15
Margin Analysis
Gross Profit Margin %	63.81	64.42	68.84	68.05	67.62
SG&A Margin	44.03	43.77	52.3	50.42	49.72
EBITDA Margin %	18.83	19.61	18.92	19.57	19.48
EBITA Margin %	15.61	16.75	16.6	17.67	17.95
EBIT Margin %	15.55	16.69	16.54	17.62	17.9
Income From Continuing Operations Margin %	10.96	12.6	12.52	12.49	12.67
Net Income Margin %	10.84	12.45	12.41	12.27	12.49
Net Avail. For Common Margin %	10.84	12.45	12.41	12.27	12.49
Normalized Net Income Margin	9.81	10.79	10.53	11.06	11.17
Levered Free Cash Flow Margin	10.34	16.39	12.1	10.31	11.48
Unlevered Free Cash Flow Margin	10.34	16.39	12.1	10.31	11.48
Asset Turnover
Asset Turnover	0.63	0.64	0.78	0.81	0.83
Fixed Assets Turnover	2.24	2.28	2.86	3.06	3.18
Receivables Turnover (Average Receivables)	5.18	5.54	6.7	6.43	6
Inventory Turnover (Average Inventory)	2.24	2.37	2.51	2.5	2.55
Short Term Liquidity
Current Ratio	6.65	5.92	5.24	4.87	5.38
Quick Ratio	5.5	5	4.36	4.04	4.29
Operating Cash Flow to Current Liabilities	0.96	1.05	0.61	0.73	0.98
Days Sales Outstanding (Average Receivables)	70.6	65.84	54.47	56.75	60.99
Days Outstanding Inventory (Average Inventory)	163.09	154.15	145.42	146.04	143.78
Average Days Payable Outstanding	48.8	49.45	51.54	52.52	51.98
Cash Conversion Cycle (Average Days)	184.89	170.54	148.34	150.27	152.8
Long Term Solvency
Total Debt/Equity	2.34	2.13	1.92	1.72	1.54
Total Debt / Total Capital	2.29	2.08	1.88	1.69	1.51
LT Debt/Equity	2.13	1.91	1.74	1.55	1.38
Long-Term Debt / Total Capital	2.08	1.87	1.71	1.53	1.36
Total Liabilities / Total Assets	34.74	35.07	31.78	31.12	29.51
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	0.13	0.11	0.09	0.07	0.07
Net Debt / EBITDA	-2.89	-2.98	-2.48	-2.28	-2.28
Total Debt / (EBITDA - Capex)	0.15	0.11	0.09	0.08	0.07
Net Debt / (EBITDA - Capex)	-3.47	-3.1	-2.61	-2.43	-2.4
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-12.51	-1.1	19.25	2.3	2.03
Gross Profit, 1 Yr. Growth %	-13.43	-0.15	27.43	1.12	1.39
EBITDA, 1 Yr. Growth %	-29.33	2.99	15.07	5.85	1.54
EBITA, 1 Yr. Growth %	-32.58	6.14	18.14	8.95	3.63
EBIT, 1 Yr. Growth %	-32.79	6.17	18.21	8.98	3.63
Earnings From Cont. Operations, 1 Yr. Growth %	-22.42	13.69	18.49	2.09	3.52
Net Income, 1 Yr. Growth %	-22.25	13.62	18.89	1.11	3.87
Normalized Net Income, 1 Yr. Growth %	-32.67	8.71	16.42	7.45	3.02
Diluted EPS Before Extra, 1 Yr. Growth %	-22.25	13.62	18.89	1.11	3.87
Accounts Receivable, 1 Yr. Growth %	-14.65	0.84	-3.49	17.03	2.8
Inventory, 1 Yr. Growth %	-6.54	-9.25	7.08	3.78	-0.68
Net Property, Plant and Equip., 1 Yr. Growth %	-0.82	-4.27	-6.12	-2.41	-1.42
Total Assets, 1 Yr. Growth %	-3.93	0.49	-4.56	0.61	-1
Tangible Book Value, 1 Yr. Growth %	-1.31	-0.1	0.28	0.88	0.75
Common Equity, 1 Yr. Growth %	-1.42	-0.1	0.25	1.41	1.3
Cash From Operations, 1 Yr. Growth %	-28.25	23.95	-35.51	30.44	19.66
Capital Expenditures, 1 Yr. Growth %	-10.75	-77	45.21	34.8	-14.95
Levered Free Cash Flow, 1 Yr. Growth %	-42.4	56.8	-11.94	-12.86	13.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-42.4	56.8	-11.94	-12.86	13.6
Dividend Per Share, 1 Yr. Growth %	2.5	2.44	2.38	2.33	2.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-5.32	-6.98	8.6	10.45	2.17
Gross Profit, 2 Yr. CAGR %	-5.75	-7.03	12.8	13.52	1.26
EBITDA, 2 Yr. CAGR %	-14.14	-14.69	8.86	10.37	3.68
EBITA, 2 Yr. CAGR %	-15.71	-15.41	11.98	13.45	6.25
EBIT, 2 Yr. CAGR %	-15.7	-15.53	12.02	13.5	6.27
Earnings From Cont. Operations, 2 Yr. CAGR %	-15.3	-6.08	16.07	9.98	2.8
Net Income, 2 Yr. CAGR %	-15.36	-6.01	16.23	9.64	2.48
Normalized Net Income, 2 Yr. CAGR %	-15.7	-14.45	12.5	11.85	5.21
Diluted EPS Before Extra, 2 Yr. CAGR %	-15.17	-6.01	16.23	9.64	2.48
Accounts Receivable, 2 Yr. CAGR %	-11.43	-7.23	-1.35	6.27	9.68
Inventory, 2 Yr. CAGR %	-0.57	-7.9	-1.42	5.42	1.53